Skip to content

Construction of a Multidisciplinary Diagnosis and Treatment Database for Vascular Anomalies and Analysis of Clinical and Imaging Characteristics and Diagnostic-Treatment Decision-Making: A Single-Center Retrospective and Prospective Observational Study

Construction of a Multidisciplinary Diagnosis and Treatment Database for Vascular Anomalies and Analysis of Clinical and Imaging Characteristics and Diagnostic-Treatment Decision-Making: A Single-Center Retrospective and Prospective Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125478
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular anomalies

Interventions

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who visited West China Hospital, Sichuan University and entered the multidisciplinary diagnosis and treatment (MDT) discussion process for vascular anomalies; 2. Patients clinically diagnosed with vascular tumors, vascular malformations, or related syndromes; 3. Patients of any age, including children, adults, and older adults; 4. Patients with basic clinical data and at least one type of imaging data, such as ultrasound, MRI, or CT; 5. Patients with MDT consultation records.

Exclusion criteria

Exclusion criteria: Patients meeting any of the following criteria will be excluded: 1. Patients with an unclear diagnosis that cannot be classified as vascular tumors, vascular malformations, or related syndromes; 2. Patients lacking basic clinical data or imaging data sufficient to support the main analysis; 3. Patients lacking MDT consultation records; 4. Duplicate cases: For patients with multiple visits or multiple entries into the MDT database, duplicate records will not be repeatedly included in the main analysis. The main analysis will be based on the record from the patient’s first entry into the MDT process for vascular anomalies with a documented MDT recommendation; subsequent entries into the MDT process may be used as follow-up data or data on the subsequent diagnostic and treatment process for descriptive analysis.

Design outcomes

Primary

MeasureTime frame
Whether the MDT recommendation is interventional;

Secondary

MeasureTime frame
MDT recommendations corresponding to different disease types and imaging phenotypes;Implementation of MDT recommendations;Re-entry into the MDT discussion process;Changes in lesion-related clinical manifestations;

Countries

China

Contacts

Public ContactJiang Xian

West China Hospital of Sichuan University

jiangxian@scu.edu.cn+86 189 8060 1693

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026